Jeffrey Farrow
2019 - Global Blood Therapeutics
In 2019, Jeffrey Farrow earned a total compensation of $3.2M as Chief Financial Officer at Global Blood Therapeutics, a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $244,000 |
|---|---|
| Option Awards | $1,267,784 |
| Salary | $440,625 |
| Stock Awards | $1,211,000 |
| Other | $5,000 |
| Total | $3,168,409 |
Farrow received $1.3M in option awards, accounting for 40% of the total pay in 2019.
Farrow also received $244K in non-equity incentive plan, $440.6K in salary, $1.2M in stock awards and $5K in other compensation.
Rankings
In 2019, Jeffrey Farrow's compensation ranked 3,859th out of 13,971 executives tracked by ExecPay. In other words, Farrow earned more than 72.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,859 out of 13,971 | 72nd |
Division Manufacturing | 1,392 out of 5,701 | 76th |
Major group Chemicals And Allied Products | 490 out of 2,200 | 78th |
Industry group Drugs | 414 out of 1,886 | 78th |
Industry Pharmaceutical Preparations | 315 out of 1,398 | 78th |
Source: SEC filing on April 28, 2021.
Farrow's colleagues
We found four more compensation records of executives who worked with Jeffrey Farrow at Global Blood Therapeutics in 2019.